期刊文献+

高浓度硝酸甘油对肿瘤细胞MMP-9/TIMP-1表达的调控 被引量:2

Regulation of MMP-9/TIMP-1 Expression in High Concentration GTN Treated Tumor Cells
下载PDF
导出
摘要 利用基因芯片、RT-PCR技术和ELISA方法观察硝酸甘油(GTN)作为一氧化氮供体对人宫颈癌细胞(Hela)MMP-9/TIMP-1基因及蛋白表达的调控。通过基因芯片对肿瘤转移相关基因的表达进行筛选,应用RT-PCR技术对MMP-9/TIMP-1基因表达进行观察,ELISA方法测定细胞培养液中MMP-9/TIMP-1蛋白浓度并计算二者比值。结果显示,培养液GTN浓度为40μg/mL时,细胞中多个肿瘤相关基因表达改变;实验组与对照组比较,细胞MMP-9基因表达有大幅度下降,TIMP-1基因表达改变不明显;实验组细胞培养液MMP-9蛋白浓度也出现明显降低,TIMP-1无显著改变,MMP-9/TIMP-1比值变化显著。结论:硝酸甘油在一定浓度下能够调控肿瘤细胞的基因表达并改变MMP-9/TIMP-1的动态平衡。 To investigate the regulation of MMP-9/TIMP-1 expressions in glyceryl trinitrate(GTN) treated Hela cells.The Hela cells were treated with GTN that acted as the donor of nitric oxide.The microarray technique was performed to analyze gene expression profiles related tumor angiogenesis and metastasis.MMP-9 and TIMP-1 gene expressions in treated Hela cells were examined through RT-PCR.ELISA assay was applied to determine the protein concentrations of MMP-9 and TIMP-1 in culture medium and calculate the MMP-9/TIMP-1 ratio.The results showed that some gene expressions were changed in Hela cells treated with 40μg/ml GTN in culture medium.The expression of MMP-9 in GTN group was greatly lower than that in control group,but the expression of TIMP-1 was not obviously changed.MMP-9 concentration in culture medium reduced dramatically,but no changed for TIMP-1.The ratio of MMP-9/TIMP-1 was altered statistically.The results indicate that glyceryl trinitrate in certain concentration could regulate the gene expression in tumor cell and shift the production balance of MMP-9 and TIMP-1.
出处 《标记免疫分析与临床》 CAS 2010年第4期247-250,共4页 Labeled Immunoassays and Clinical Medicine
基金 国家科技支撑计划基金资助项目(2009BAI86B05)
关键词 硝酸甘油(GTN) 一氧化氮(NO) RT-PCR 酶联免疫吸附测定 肿瘤 Glyceryl trinitrate Nitric oxide RT-PCR ELISA Tumor
  • 相关文献

参考文献3

二级参考文献21

  • 1张阳东,田亚平,汪德清,宋淑珍,董矜,姜辉.硝酸甘油消化道吸收后在动物体内的代谢研究[J].中国实验动物学报,2004,12(3):156-158. 被引量:1
  • 2姜辉,田亚平,董矜,张阳东.应用基因芯片技术观察硝酸甘油对肿瘤细胞血管生成相关基因表达的调控[J].中国临床康复,2004,8(29):6413-6415. 被引量:7
  • 3杜传书.改良红细胞还原型谷胱甘肽二硫双硝基苯甲酸定量测定法[J].中华医学检验杂志,1984,7(3):172-172.
  • 4Feelisch M, Brands F, Kelm M. Human endothelial cells bioactivate organic nitric oxide: implications for the reinforcement of endothelial defence mechanisms. Eur J Clin Invest,1995,25:737-745.
  • 5Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA, 2002,99:8306-8311.
  • 6Kearney MF, Brien JF, Marks GS, et al. Thiol agents separate nitric oxide formation from vasodilation induced by glyceryl trinitrate. Drug Metab Dispos, 1998,26:547-551.
  • 7Ustyugova IV, Zeman C, Dhanwada K, et al. Nitrates/nitrites alter human lymphocyte proliferation and cytokine production. Arch Environ Contam Toxicol, 2002,43:270-276.
  • 8Thomas WJ, Thomas DL, Knezetic JA, et al. The role of oxygen-derived free radicals and nitric oxide in cytokine-induced antiproliferation of pancreatic cancer cells. Pancreas, 2002,24:161-168.
  • 9Bates JN, Harrison DG, Myers PR, et al. EDRF: nitrosylated compound or authentic nitric oxide. Basic Res Cardiol, 1991,86:17-26.
  • 10Kohno M, Masumizu T, Mori A. ESR demonstration of nitric oxide production from nitroglycerin and sodium nitrite in the blood of rats. Free Radic boil Med, 1995,18:451-457.

共引文献43

同被引文献31

  • 1魏莉,徐盈.基质金属蛋白酶9在老年肺癌中的表达及临床意义[J].中国老年学杂志,2014,34(1):89-90. 被引量:8
  • 2Seabra AB, De Lima R, Calder6n M. Nitric oxide releasing nanoma-terials for cancer treatment: current status and perspectives[ J]. Curr Top Med Chem, 2015, 15(4) : 298-308.
  • 3Carradori S, Mollica A, De Monte C, et al. Nitric oxide donors and selective carbonic anhydrase inhibitors: a dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis [ J ]. Molecules, 2015, 20 ( 4 ) : 5667-5679. DOI: 10. 3390/mole- cules20045667.
  • 4Reynolds MM, Witzeling SD, Damodaran VB, et al. Applications for nitric oxide in halting proliferation of tumor cells [ J ]. Biochem Bio- phys Res Commun, 2013, 431 (4): 647-651. DOI: 10. 1016/j. bbrc. 2013.01. 041.
  • 5Hagen T, Taylor CT, Lam F, et al. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1 atpha[ J ]. Science, 2003, 302 (5652) : 1975-1978. DOI : 10.1126/science. 1088805.
  • 6Cheng H, Wang L, Mollica M, et al. Nitric oxide in cancer metasta- sis[J]. Cancer Lett, 2014, 353(1) : 1-7. DOI: 10. 1016/j. canlet. 2014.07. 014.
  • 7Frederiksen LJ, Sullivan R, Maxwell LR, et al. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling[ J]. Clin Cancer Res, 2007, 13(7): 2199-2206. DOI: 10. 1158/1078-0432. CCR- 06-1807.
  • 8Li QC, Liang Y, Tian Y, et al. Arctigenin induces apoptosis in colon cancer cells through ROS/p38MAPK pathway [ J]. J BUON, 2016, 21(1): 87-94..
  • 9Serafim RA, Primi MC, Trossini GH, et al. Nitric oxide : state of the art in drug design[J]. Curr Med Chem, 2012, 19(3) : 386-405.
  • 10Basudhar D, Cheng RC, Bharadwaj G, et al. Chemotherapeutic po- tential of diazeniumdiolate-based aspirin prodrugs in breast cancer [J]. Free Radic Biol Med, 2015, 83(83): 101-114. DOI: 10. 1016/j. freeradbiomed. 2015.01. 029.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部